), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce updates on the proposed self-medicating DPI Inhalation Device for Asthma/COPD and our Cannabinoid ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Tyvaso DPI is a drug-device combination therapy that consists of a dry powder formulation of treprostinil and a small, portable, dry powder inhaler. The Food and Drug Administration (FDA) has approved ...
A simple, one-part DPI aims to make inhalation drug treatment more accessible and affordable. Hovione Technology, a Hovione Ventures company, announced in an April 15, 2019 press release that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results